D.E. Shaw & Co’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.29M | Sell |
13,300
-59,600
| -82% | -$30M | ﹤0.01% | 2004 |
|
|
2025
Q4 | $34M | Sell |
72,900
-9,300
| -11% | -$4.32M | 0.02% | 918 |
|
|
2025
Q3 | $35M | Buy |
82,200
+18,800
| +30% | +$7.29M | 0.02% | 841 |
|
|
2025
Q2 | $24.3M | Buy |
63,400
+3,100
| +5% | +$1.12M | 0.02% | 917 |
|
|
2025
Q1 | $20.8M | Buy |
60,300
+20,000
| +50% | +$6.43M | 0.02% | 922 |
|
|
2024
Q4 | $12.1M | Buy |
40,300
+12,400
| +44% | +$4.33M | 0.01% | 1369 |
|
|
2024
Q3 | $11.3M | Buy |
+27,900
| New | +$10.2M | 0.01% | 1342 |
|
|
2023
Q3 | – | Sell |
-33,600
| Closed | -$10.2M | – | 4349 |
|
|
2023
Q2 | $10.2M | Buy |
+33,600
| New | +$9.34M | 0.01% | 1326 |
|
|
2022
Q2 | – | Sell |
-40,000
| Closed | -$10M | – | 5504 |
|
|
2022
Q1 | $10M | Buy |
+40,000
| New | +$10M | 0.01% | 1586 |
|
|
2021
Q2 | – | Sell |
-20,300
| Closed | -$3.82M | – | 4851 |
|
|
2021
Q1 | $3.82M | Sell |
20,300
-15,700
| -44% | -$2.77M | ﹤0.01% | 2061 |
|
|
2020
Q4 | $5.92M | Buy |
+36,000
| New | +$5.26M | 0.01% | 1746 |
|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$4.85M | – | 3965 |
|
|
2020
Q2 | $4.85M | Buy |
50,000
+40,000
| +400% | +$4.16M | 0.01% | 1676 |
|
|
2020
Q1 | $899K | Sell |
10,000
-85,500
| -90% | -$11.1M | ﹤0.01% | 2815 |
|
|
2019
Q4 | $14.1M | Sell |
95,500
-3,600
| -4% | -$483K | 0.02% | 1004 |
|
|
2019
Q3 | $11.9M | Buy |
99,100
+5,600
| +6% | +$724K | 0.01% | 1066 |
|
|
2019
Q2 | $12.6M | Hold |
93,500
| – | – | 0.02% | 1009 |
|
|
2019
Q1 | $12.2M | Sell |
93,500
-9,300
| -9% | -$1.25M | 0.02% | 984 |
|
|
2018
Q4 | $12.8M | Buy |
102,800
+39,200
| +62% | +$5.26M | 0.02% | 936 |
|
|
2018
Q3 | $8.85M | Buy |
63,600
+32,300
| +103% | +$4.02M | 0.01% | 1192 |
|
|
2018
Q2 | $3.21M | Buy |
31,300
+19,900
| +175% | +$2.01M | ﹤0.01% | 1863 |
|
|
2018
Q1 | $1.11M | Buy |
+11,400
| New | +$1.11M | ﹤0.01% | 2424 |
|
|
2016
Q1 | – | Sell |
-50,000
| Closed | -$3.38M | – | 3564 |
|
|
2015
Q4 | $3.38M | Sell |
50,000
-40,000
| -44% | -$2.79M | 0.01% | 1722 |
|
|
2015
Q3 | $6.96M | Hold |
90,000
| – | – | 0.01% | 1180 |
|
|
2015
Q2 | $8.16M | Buy |
90,000
+40,000
| +80% | +$3.2M | 0.01% | 1137 |
|
|
2015
Q1 | $3.76M | Sell |
50,000
-451,800
| -90% | -$32.4M | 0.01% | 1560 |
|
|
2014
Q4 | $36.8M | Buy |
501,800
+385,000
| +330% | +$27.1M | 0.05% | 466 |
|
|
2014
Q3 | $8.24M | Buy |
116,800
+57,800
| +98% | +$3.82M | 0.01% | 1208 |
|
|
2014
Q2 | $3.33M | Buy |
59,000
+20,000
| +51% | +$1.06M | ﹤0.01% | 1910 |
|
|
2014
Q1 | $2.05M | Buy |
39,000
+10,000
| +34% | +$498K | ﹤0.01% | 2364 |
|
|
2013
Q4 | $1.38M | Buy |
+29,000
| New | +$1.34M | ﹤0.01% | 2876 |
|
|
2013
Q3 | – | Sell |
-7,700
| Closed | -$278K | – | 4356 |
|
|
2013
Q2 | $278K | Buy |
+7,700
| New | +$298K | ﹤0.01% | 3611 |
|
Other funds holding HCA
VCM
VPM
D.E. Shaw & Co's HCA Position: Q1 2026 in Review
D.E. Shaw & Co increased its HCA Healthcare (HCA) stake by 11% in Q1 2026, buying an estimated $2.42M and bringing the position to 49,935 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #1044.
D.E. Shaw & Co first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $235M in Q3 2015. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- D.E. Shaw & Co held 49,935 shares of HCA Healthcare worth $23.6M as of Q1 2026.
- D.E. Shaw & Co bought 4,816 HCA Healthcare shares in Q1 2026, an estimated $2.42M.
- HCA Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1044 holding.
- D.E. Shaw & Co first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
- D.E. Shaw & Co's HCA Healthcare position peaked at $235M in Q3 2015.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.